nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNQ4—ear—melanoma	0.0286	0.0746	CbGeAlD
Dalfampridine—KCNQ1—ear—melanoma	0.0164	0.0429	CbGeAlD
Dalfampridine—KCNS3—hair follicle—melanoma	0.0118	0.0307	CbGeAlD
Dalfampridine—KCNV2—eye—melanoma	0.0111	0.0289	CbGeAlD
Dalfampridine—KCNV2—retina—melanoma	0.011	0.0286	CbGeAlD
Dalfampridine—KCNB1—eye—melanoma	0.00912	0.0238	CbGeAlD
Dalfampridine—KCNC3—eye—melanoma	0.00885	0.0231	CbGeAlD
Dalfampridine—KCNG4—head—melanoma	0.00829	0.0216	CbGeAlD
Dalfampridine—KCNH4—head—melanoma	0.00829	0.0216	CbGeAlD
Dalfampridine—KCNB2—head—melanoma	0.00829	0.0216	CbGeAlD
Dalfampridine—KCNS1—eye—melanoma	0.00819	0.0214	CbGeAlD
Dalfampridine—KCNH5—head—melanoma	0.00758	0.0198	CbGeAlD
Dalfampridine—KCNQ4—eye—melanoma	0.00752	0.0196	CbGeAlD
Dalfampridine—KCNQ4—retina—melanoma	0.00746	0.0195	CbGeAlD
Dalfampridine—KCNQ5—eye—melanoma	0.00732	0.0191	CbGeAlD
Dalfampridine—KCNQ5—retina—melanoma	0.00725	0.0189	CbGeAlD
Dalfampridine—KCNS2—head—melanoma	0.00705	0.0184	CbGeAlD
Dalfampridine—KCNA6—head—melanoma	0.00705	0.0184	CbGeAlD
Dalfampridine—KCNV1—head—melanoma	0.00663	0.0173	CbGeAlD
Dalfampridine—KCNV2—head—melanoma	0.00628	0.0164	CbGeAlD
Dalfampridine—KCNC2—head—melanoma	0.00599	0.0156	CbGeAlD
Dalfampridine—KCNH1—head—melanoma	0.00599	0.0156	CbGeAlD
Dalfampridine—KCNG3—head—melanoma	0.00599	0.0156	CbGeAlD
Dalfampridine—KCNC1—mammalian vulva—melanoma	0.00597	0.0156	CbGeAlD
Dalfampridine—KCNA5—retina—melanoma	0.00594	0.0155	CbGeAlD
Dalfampridine—KCNS3—eye—melanoma	0.00587	0.0153	CbGeAlD
Dalfampridine—KCNQ1—neck—melanoma	0.00581	0.0152	CbGeAlD
Dalfampridine—KCNQ2—eye—melanoma	0.00541	0.0141	CbGeAlD
Dalfampridine—KCNG1—head—melanoma	0.00534	0.0139	CbGeAlD
Dalfampridine—KCNH3—head—melanoma	0.00534	0.0139	CbGeAlD
Dalfampridine—KCNH8—head—melanoma	0.00517	0.0135	CbGeAlD
Dalfampridine—KCNB1—head—melanoma	0.00517	0.0135	CbGeAlD
Dalfampridine—KCNS3—skin of body—melanoma	0.00511	0.0133	CbGeAlD
Dalfampridine—KCNC3—head—melanoma	0.00502	0.0131	CbGeAlD
Dalfampridine—KCNA4—head—melanoma	0.00489	0.0127	CbGeAlD
Dalfampridine—KCNA3—head—melanoma	0.00489	0.0127	CbGeAlD
Dalfampridine—KCNS3—mammalian vulva—melanoma	0.00466	0.0122	CbGeAlD
Dalfampridine—KCNA2—head—melanoma	0.00465	0.0121	CbGeAlD
Dalfampridine—KCNS1—head—melanoma	0.00465	0.0121	CbGeAlD
Dalfampridine—KCNA1—retina—melanoma	0.00445	0.0116	CbGeAlD
Dalfampridine—KCND1—head—melanoma	0.00445	0.0116	CbGeAlD
Dalfampridine—KCNC4—head—melanoma	0.00445	0.0116	CbGeAlD
Dalfampridine—Infestation—Vemurafenib—melanoma	0.00442	0.0205	CcSEcCtD
Dalfampridine—Infestation NOS—Vemurafenib—melanoma	0.00442	0.0205	CcSEcCtD
Dalfampridine—KCNC1—head—melanoma	0.00427	0.0111	CbGeAlD
Dalfampridine—KCNQ4—head—melanoma	0.00427	0.0111	CbGeAlD
Dalfampridine—KCNH7—head—melanoma	0.00427	0.0111	CbGeAlD
Dalfampridine—KCNQ5—head—melanoma	0.00415	0.0108	CbGeAlD
Dalfampridine—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00398	0.0184	CcSEcCtD
Dalfampridine—Laryngeal pain—Docetaxel—melanoma	0.00394	0.0183	CcSEcCtD
Dalfampridine—Connective tissue disorder—Vemurafenib—melanoma	0.0039	0.0181	CcSEcCtD
Dalfampridine—KCNF1—head—melanoma	0.00381	0.00993	CbGeAlD
Dalfampridine—Angiopathy—Vemurafenib—melanoma	0.0036	0.0167	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vemurafenib—melanoma	0.00357	0.0166	CcSEcCtD
Dalfampridine—KCNQ1—mammalian vulva—melanoma	0.00343	0.00895	CbGeAlD
Dalfampridine—KCNA3—lymph node—melanoma	0.00342	0.00893	CbGeAlD
Dalfampridine—KCNA5—head—melanoma	0.00341	0.00889	CbGeAlD
Dalfampridine—Back pain—Vemurafenib—melanoma	0.00334	0.0155	CcSEcCtD
Dalfampridine—KCNS3—head—melanoma	0.00333	0.0087	CbGeAlD
Dalfampridine—KCNQ3—head—melanoma	0.00333	0.0087	CbGeAlD
Dalfampridine—KCNA2—lymph node—melanoma	0.00325	0.00849	CbGeAlD
Dalfampridine—KCNC4—lymph node—melanoma	0.00311	0.00812	CbGeAlD
Dalfampridine—KCNQ2—head—melanoma	0.00307	0.00801	CbGeAlD
Dalfampridine—KCNH6—head—melanoma	0.00304	0.00794	CbGeAlD
Dalfampridine—Chest discomfort—Docetaxel—melanoma	0.00303	0.0141	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00292	0.0135	CcSEcCtD
Dalfampridine—KCNQ5—lymph node—melanoma	0.00291	0.00759	CbGeAlD
Dalfampridine—KCND2—head—melanoma	0.00291	0.00758	CbGeAlD
Dalfampridine—Anaphylactic shock—Vemurafenib—melanoma	0.00282	0.0131	CcSEcCtD
Dalfampridine—Infection—Vemurafenib—melanoma	0.0028	0.013	CcSEcCtD
Dalfampridine—Nervous system disorder—Vemurafenib—melanoma	0.00276	0.0128	CcSEcCtD
Dalfampridine—Skin disorder—Vemurafenib—melanoma	0.00274	0.0127	CcSEcCtD
Dalfampridine—Hypotension—Vemurafenib—melanoma	0.00263	0.0122	CcSEcCtD
Dalfampridine—KCNA1—head—melanoma	0.00255	0.00664	CbGeAlD
Dalfampridine—KCND3—head—melanoma	0.00253	0.00661	CbGeAlD
Dalfampridine—KCNQ1—head—melanoma	0.00245	0.0064	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00243	0.0113	CcSEcCtD
Dalfampridine—Constipation—Vemurafenib—melanoma	0.00241	0.0112	CcSEcCtD
Dalfampridine—KCNA5—lymph node—melanoma	0.00238	0.00622	CbGeAlD
Dalfampridine—KCNS3—lymph node—melanoma	0.00233	0.00609	CbGeAlD
Dalfampridine—Urinary tract infection—Carmustine—melanoma	0.00227	0.0105	CcSEcCtD
Dalfampridine—Infestation NOS—Temozolomide—melanoma	0.00226	0.0105	CcSEcCtD
Dalfampridine—Infestation—Temozolomide—melanoma	0.00226	0.0105	CcSEcCtD
Dalfampridine—Urinary tract infection—Temozolomide—melanoma	0.00219	0.0102	CcSEcCtD
Dalfampridine—Hypersensitivity—Vemurafenib—melanoma	0.00208	0.00963	CcSEcCtD
Dalfampridine—Connective tissue disorder—Carmustine—melanoma	0.00206	0.00956	CcSEcCtD
Dalfampridine—Asthenia—Vemurafenib—melanoma	0.00202	0.00938	CcSEcCtD
Dalfampridine—Connective tissue disorder—Temozolomide—melanoma	0.00199	0.00924	CcSEcCtD
Dalfampridine—Dizziness—Vemurafenib—melanoma	0.00186	0.00864	CcSEcCtD
Dalfampridine—Angiopathy—Temozolomide—melanoma	0.00184	0.00853	CcSEcCtD
Dalfampridine—Mental disorder—Carmustine—melanoma	0.00184	0.00852	CcSEcCtD
Dalfampridine—Immune system disorder—Temozolomide—melanoma	0.00183	0.00849	CcSEcCtD
Dalfampridine—Mediastinal disorder—Temozolomide—melanoma	0.00183	0.00847	CcSEcCtD
Dalfampridine—Vomiting—Vemurafenib—melanoma	0.00179	0.00831	CcSEcCtD
Dalfampridine—Chest pain—Bleomycin—melanoma	0.00178	0.00826	CcSEcCtD
Dalfampridine—Rash—Vemurafenib—melanoma	0.00178	0.00824	CcSEcCtD
Dalfampridine—Mental disorder—Temozolomide—melanoma	0.00178	0.00824	CcSEcCtD
Dalfampridine—Dermatitis—Vemurafenib—melanoma	0.00177	0.00823	CcSEcCtD
Dalfampridine—KCND3—lymph node—melanoma	0.00177	0.00463	CbGeAlD
Dalfampridine—Back pain—Carmustine—melanoma	0.00177	0.00819	CcSEcCtD
Dalfampridine—Headache—Vemurafenib—melanoma	0.00176	0.00819	CcSEcCtD
Dalfampridine—Nasopharyngitis—Docetaxel—melanoma	0.00174	0.00808	CcSEcCtD
Dalfampridine—Confusional state—Bleomycin—melanoma	0.00172	0.00798	CcSEcCtD
Dalfampridine—KCNQ1—lymph node—melanoma	0.00172	0.00448	CbGeAlD
Dalfampridine—Tremor—Carmustine—melanoma	0.00171	0.00793	CcSEcCtD
Dalfampridine—Anaphylactic shock—Bleomycin—melanoma	0.00171	0.00792	CcSEcCtD
Dalfampridine—Back pain—Temozolomide—melanoma	0.00171	0.00792	CcSEcCtD
Dalfampridine—Infection—Bleomycin—melanoma	0.0017	0.00787	CcSEcCtD
Dalfampridine—Nausea—Vemurafenib—melanoma	0.00167	0.00776	CcSEcCtD
Dalfampridine—Tremor—Temozolomide—melanoma	0.00165	0.00767	CcSEcCtD
Dalfampridine—Angioedema—Temozolomide—melanoma	0.00161	0.00748	CcSEcCtD
Dalfampridine—Hypotension—Bleomycin—melanoma	0.00159	0.0074	CcSEcCtD
Dalfampridine—Convulsion—Carmustine—melanoma	0.00158	0.00734	CcSEcCtD
Dalfampridine—Infection—Dactinomycin—melanoma	0.00158	0.00734	CcSEcCtD
Dalfampridine—Chest pain—Carmustine—melanoma	0.00155	0.00721	CcSEcCtD
Dalfampridine—Anxiety—Carmustine—melanoma	0.00155	0.00718	CcSEcCtD
Dalfampridine—Paraesthesia—Bleomycin—melanoma	0.00153	0.00711	CcSEcCtD
Dalfampridine—Convulsion—Temozolomide—melanoma	0.00153	0.00709	CcSEcCtD
Dalfampridine—Dyspnoea—Bleomycin—melanoma	0.00152	0.00706	CcSEcCtD
Dalfampridine—Confusional state—Carmustine—melanoma	0.0015	0.00697	CcSEcCtD
Dalfampridine—Infestation—Docetaxel—melanoma	0.0015	0.00696	CcSEcCtD
Dalfampridine—Infestation NOS—Docetaxel—melanoma	0.0015	0.00696	CcSEcCtD
Dalfampridine—Anxiety—Temozolomide—melanoma	0.0015	0.00694	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00149	0.00692	CcSEcCtD
Dalfampridine—Infection—Carmustine—melanoma	0.00148	0.00687	CcSEcCtD
Dalfampridine—Confusional state—Temozolomide—melanoma	0.00145	0.00673	CcSEcCtD
Dalfampridine—Anaphylactic shock—Temozolomide—melanoma	0.00144	0.00668	CcSEcCtD
Dalfampridine—Infection—Temozolomide—melanoma	0.00143	0.00664	CcSEcCtD
Dalfampridine—Nervous system disorder—Temozolomide—melanoma	0.00141	0.00655	CcSEcCtD
Dalfampridine—Feeling abnormal—Bleomycin—melanoma	0.00141	0.00652	CcSEcCtD
Dalfampridine—Skin disorder—Temozolomide—melanoma	0.0014	0.00649	CcSEcCtD
Dalfampridine—Hypotension—Carmustine—melanoma	0.00139	0.00646	CcSEcCtD
Dalfampridine—Urticaria—Bleomycin—melanoma	0.00136	0.00629	CcSEcCtD
Dalfampridine—Insomnia—Carmustine—melanoma	0.00135	0.00625	CcSEcCtD
Dalfampridine—Paraesthesia—Carmustine—melanoma	0.00134	0.00621	CcSEcCtD
Dalfampridine—Dyspnoea—Carmustine—melanoma	0.00133	0.00616	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—melanoma	0.00132	0.00614	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—melanoma	0.00131	0.00609	CcSEcCtD
Dalfampridine—Insomnia—Temozolomide—melanoma	0.0013	0.00604	CcSEcCtD
Dalfampridine—Paraesthesia—Temozolomide—melanoma	0.00129	0.006	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Carmustine—melanoma	0.00129	0.00597	CcSEcCtD
Dalfampridine—Dyspnoea—Temozolomide—melanoma	0.00128	0.00595	CcSEcCtD
Dalfampridine—Constipation—Carmustine—melanoma	0.00127	0.00591	CcSEcCtD
Dalfampridine—Dyspepsia—Temozolomide—melanoma	0.00127	0.00588	CcSEcCtD
Dalfampridine—Hypersensitivity—Bleomycin—melanoma	0.00126	0.00583	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Temozolomide—melanoma	0.00124	0.00577	CcSEcCtD
Dalfampridine—Constipation—Temozolomide—melanoma	0.00123	0.00571	CcSEcCtD
Dalfampridine—Feeling abnormal—Carmustine—melanoma	0.00123	0.0057	CcSEcCtD
Dalfampridine—Asthenia—Bleomycin—melanoma	0.00122	0.00568	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—melanoma	0.00122	0.00567	CcSEcCtD
Dalfampridine—Immune system disorder—Docetaxel—melanoma	0.00122	0.00565	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—melanoma	0.00121	0.00563	CcSEcCtD
Dalfampridine—Feeling abnormal—Temozolomide—melanoma	0.00119	0.0055	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—melanoma	0.00118	0.00548	CcSEcCtD
Dalfampridine—Hypersensitivity—Dactinomycin—melanoma	0.00117	0.00544	CcSEcCtD
Dalfampridine—Urticaria—Temozolomide—melanoma	0.00114	0.00531	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—melanoma	0.00114	0.0053	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—melanoma	0.00113	0.00526	CcSEcCtD
Dalfampridine—Hypersensitivity—Carmustine—melanoma	0.0011	0.00509	CcSEcCtD
Dalfampridine—Vomiting—Bleomycin—melanoma	0.00109	0.00503	CcSEcCtD
Dalfampridine—Rash—Bleomycin—melanoma	0.00108	0.00499	CcSEcCtD
Dalfampridine—Dermatitis—Bleomycin—melanoma	0.00108	0.00499	CcSEcCtD
Dalfampridine—Asthenia—Carmustine—melanoma	0.00107	0.00496	CcSEcCtD
Dalfampridine—Hypersensitivity—Temozolomide—melanoma	0.00106	0.00492	CcSEcCtD
Dalfampridine—Asthenia—Temozolomide—melanoma	0.00103	0.00479	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—melanoma	0.00102	0.00472	CcSEcCtD
Dalfampridine—Nausea—Bleomycin—melanoma	0.00101	0.0047	CcSEcCtD
Dalfampridine—Vomiting—Dactinomycin—melanoma	0.00101	0.0047	CcSEcCtD
Dalfampridine—Rash—Dactinomycin—melanoma	0.001	0.00466	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—melanoma	0.000999	0.00463	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000992	0.0046	CcSEcCtD
Dalfampridine—Dizziness—Carmustine—melanoma	0.000985	0.00457	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—melanoma	0.000965	0.00448	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—melanoma	0.000957	0.00444	CcSEcCtD
Dalfampridine—Dizziness—Temozolomide—melanoma	0.000952	0.00442	CcSEcCtD
Dalfampridine—Infection—Docetaxel—melanoma	0.000951	0.00441	CcSEcCtD
Dalfampridine—Vomiting—Carmustine—melanoma	0.000947	0.00439	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—melanoma	0.000946	0.00439	CcSEcCtD
Dalfampridine—Rash—Carmustine—melanoma	0.000939	0.00436	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—melanoma	0.000939	0.00436	CcSEcCtD
Dalfampridine—Dermatitis—Carmustine—melanoma	0.000939	0.00435	CcSEcCtD
Dalfampridine—KCNH2—head—melanoma	0.000935	0.00244	CbGeAlD
Dalfampridine—Headache—Carmustine—melanoma	0.000933	0.00433	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—melanoma	0.00093	0.00431	CcSEcCtD
Dalfampridine—Vomiting—Temozolomide—melanoma	0.000915	0.00425	CcSEcCtD
Dalfampridine—Rash—Temozolomide—melanoma	0.000908	0.00421	CcSEcCtD
Dalfampridine—Dermatitis—Temozolomide—melanoma	0.000907	0.00421	CcSEcCtD
Dalfampridine—Headache—Temozolomide—melanoma	0.000902	0.00418	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—melanoma	0.000895	0.00415	CcSEcCtD
Dalfampridine—Nausea—Carmustine—melanoma	0.000885	0.00411	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—melanoma	0.000866	0.00402	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—melanoma	0.00086	0.00399	CcSEcCtD
Dalfampridine—Nausea—Temozolomide—melanoma	0.000855	0.00397	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—melanoma	0.000854	0.00396	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—melanoma	0.000843	0.00391	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—melanoma	0.000827	0.00383	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—melanoma	0.000819	0.0038	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—melanoma	0.000789	0.00366	CcSEcCtD
Dalfampridine—CYP2E1—head—melanoma	0.00072	0.00188	CbGeAlD
Dalfampridine—Hypersensitivity—Docetaxel—melanoma	0.000705	0.00327	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—melanoma	0.000687	0.00319	CcSEcCtD
Dalfampridine—KCNH2—lymph node—melanoma	0.000655	0.00171	CbGeAlD
Dalfampridine—Dizziness—Docetaxel—melanoma	0.000633	0.00294	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—melanoma	0.000609	0.00282	CcSEcCtD
Dalfampridine—Rash—Docetaxel—melanoma	0.000604	0.0028	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—melanoma	0.000603	0.0028	CcSEcCtD
Dalfampridine—Headache—Docetaxel—melanoma	0.0006	0.00278	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—melanoma	0.000569	0.00264	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—BRAF—melanoma	0.000209	0.00052	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MDM2—melanoma	0.000209	0.00052	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ITGB1—melanoma	0.000207	0.000516	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ITGB1—melanoma	0.000207	0.000516	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—VCAN—melanoma	0.000206	0.000513	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—VCAN—melanoma	0.000206	0.000513	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—VCAN—melanoma	0.000206	0.000513	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MDM2—melanoma	0.000206	0.000513	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—melanoma	0.0002	0.000498	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—melanoma	0.000197	0.00049	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—VCAN—melanoma	0.000195	0.000486	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—melanoma	0.000186	0.000464	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MAPK1—melanoma	0.000185	0.000462	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MAPK1—melanoma	0.000185	0.000462	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MAPK1—melanoma	0.000185	0.000462	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MAPK1—melanoma	0.00018	0.00045	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ITGB3—melanoma	0.000179	0.000447	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ITGB3—melanoma	0.000179	0.000447	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—melanoma	0.000178	0.000443	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—melanoma	0.000178	0.000443	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAPK1—melanoma	0.000176	0.000438	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—melanoma	0.000175	0.000437	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAP2K2—melanoma	0.000175	0.000437	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAP2K2—melanoma	0.000175	0.000437	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MDM2—melanoma	0.000175	0.000436	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MDM2—melanoma	0.000175	0.000436	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—melanoma	0.000175	0.000435	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—melanoma	0.000175	0.000435	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAP2K1—melanoma	0.000174	0.000435	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAP2K1—melanoma	0.000174	0.000435	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP17A1—melanoma	0.000174	0.000433	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP17A1—melanoma	0.000174	0.000433	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP17A1—melanoma	0.000174	0.000433	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—melanoma	0.000167	0.000416	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAC1—melanoma	0.000166	0.000415	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAC1—melanoma	0.000166	0.000415	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP17A1—melanoma	0.000165	0.00041	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNA11—melanoma	0.000164	0.000409	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNA11—melanoma	0.000164	0.000409	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNA11—melanoma	0.000164	0.000409	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAPK1—melanoma	0.000161	0.000401	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAPK1—melanoma	0.000161	0.000401	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—melanoma	0.000161	0.0004	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—FASN—melanoma	0.00016	0.0004	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—FASN—melanoma	0.00016	0.0004	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—FASN—melanoma	0.00016	0.0004	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC5A5—melanoma	0.000158	0.000393	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC5A5—melanoma	0.000158	0.000393	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC5A5—melanoma	0.000158	0.000393	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAPK1—melanoma	0.000158	0.000393	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNA11—melanoma	0.000155	0.000388	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—melanoma	0.000153	0.000382	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—melanoma	0.000153	0.000381	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—melanoma	0.000153	0.000381	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—melanoma	0.000153	0.00038	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—melanoma	0.000153	0.00038	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GNAQ—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GNAQ—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GNAQ—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD44—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD44—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD44—melanoma	0.000152	0.00038	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—FASN—melanoma	0.000152	0.000379	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A5—melanoma	0.00015	0.000373	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDK4—melanoma	0.000149	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—melanoma	0.000149	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDK4—melanoma	0.000149	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—melanoma	0.000149	0.000372	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—melanoma	0.000149	0.000371	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—melanoma	0.000149	0.000371	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—melanoma	0.000149	0.000371	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP17A1—melanoma	0.000148	0.000368	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1B1—melanoma	0.000146	0.000364	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1B1—melanoma	0.000146	0.000364	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1B1—melanoma	0.000146	0.000364	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP17A1—melanoma	0.000146	0.000363	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—melanoma	0.000145	0.000361	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GNAQ—melanoma	0.000145	0.00036	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD44—melanoma	0.000145	0.00036	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NOTCH1—melanoma	0.000144	0.000358	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NOTCH1—melanoma	0.000144	0.000358	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAPK1—melanoma	0.000143	0.000356	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCA—melanoma	0.000141	0.000352	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—melanoma	0.000141	0.000352	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAPK1—melanoma	0.000141	0.00035	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—melanoma	0.00014	0.00035	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1B1—melanoma	0.000139	0.000345	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PPARG—melanoma	0.000136	0.000338	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PPARG—melanoma	0.000136	0.000338	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—melanoma	0.000131	0.000327	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—melanoma	0.000131	0.000327	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00013	0.000323	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—melanoma	0.000129	0.000322	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—melanoma	0.000129	0.000322	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—melanoma	0.000127	0.000316	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—melanoma	0.000125	0.000311	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—melanoma	0.000125	0.000311	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAP2K1—melanoma	0.000124	0.00031	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAP2K1—melanoma	0.000124	0.00031	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—melanoma	0.000124	0.00031	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—melanoma	0.000124	0.000309	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—melanoma	0.000122	0.000305	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—melanoma	0.00012	0.0003	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—melanoma	0.00012	0.0003	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—melanoma	0.00012	0.0003	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—melanoma	0.00012	0.0003	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.00012	0.000298	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAPK1—melanoma	0.00012	0.000298	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAPK1—melanoma	0.00012	0.000298	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGF2—melanoma	0.000118	0.000295	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGF2—melanoma	0.000118	0.000295	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—melanoma	0.000118	0.000294	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—melanoma	0.000118	0.000294	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—melanoma	0.000116	0.00029	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—melanoma	0.000116	0.00029	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000116	0.000289	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—melanoma	0.000115	0.000285	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—melanoma	0.000114	0.000284	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—melanoma	0.000113	0.000281	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—melanoma	0.000111	0.000278	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—melanoma	0.000111	0.000278	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PRKCA—melanoma	0.000111	0.000276	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PRKCA—melanoma	0.000111	0.000276	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PRKCA—melanoma	0.000111	0.000276	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ERCC2—melanoma	0.00011	0.000274	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ERCC2—melanoma	0.00011	0.000274	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ERCC2—melanoma	0.00011	0.000274	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—melanoma	0.000109	0.000272	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—melanoma	0.000109	0.000272	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK1—melanoma	0.000106	0.000264	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK1—melanoma	0.000106	0.000264	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—melanoma	0.000106	0.000264	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—melanoma	0.000106	0.000264	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000105	0.000262	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PRKCA—melanoma	0.000105	0.000262	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ERCC2—melanoma	0.000104	0.00026	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—melanoma	0.000104	0.000259	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—melanoma	0.0001	0.00025	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—melanoma	0.0001	0.00025	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—melanoma	9.6e-05	0.000239	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—melanoma	9.6e-05	0.000239	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—melanoma	9.55e-05	0.000238	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—melanoma	9.55e-05	0.000238	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—melanoma	9.36e-05	0.000233	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—melanoma	9.36e-05	0.000233	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NFKB1—melanoma	9.26e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NFKB1—melanoma	9.26e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—melanoma	9.02e-05	0.000225	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—melanoma	8.71e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—melanoma	8.68e-05	0.000216	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—melanoma	8.68e-05	0.000216	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—melanoma	8.68e-05	0.000216	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—melanoma	8.51e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—melanoma	8.51e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—melanoma	8.41e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—melanoma	8.41e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PPARG—melanoma	8.37e-05	0.000209	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PPARG—melanoma	8.37e-05	0.000209	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PPARG—melanoma	8.37e-05	0.000209	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—melanoma	8.32e-05	0.000208	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—melanoma	8.32e-05	0.000208	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—melanoma	8.3e-05	0.000207	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—melanoma	8.3e-05	0.000207	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACER3—melanoma	8.28e-05	0.000206	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—melanoma	8.23e-05	0.000205	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—melanoma	8.15e-05	0.000203	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—melanoma	8.15e-05	0.000203	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—melanoma	7.95e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—melanoma	7.95e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PPARG—melanoma	7.94e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—melanoma	7.63e-05	0.00019	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—melanoma	7.63e-05	0.00019	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—melanoma	7.63e-05	0.00019	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGT2B10—melanoma	7.57e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK1—melanoma	7.57e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK1—melanoma	7.57e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—melanoma	7.57e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—melanoma	7.57e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—melanoma	7.53e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—melanoma	7.53e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—melanoma	7.53e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—melanoma	7.28e-05	0.000182	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—melanoma	7.23e-05	0.00018	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—melanoma	7.21e-05	0.00018	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—melanoma	7.21e-05	0.00018	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—melanoma	7.15e-05	0.000178	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—melanoma	7.15e-05	0.000178	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—melanoma	7.14e-05	0.000178	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HS3ST5—melanoma	7.04e-05	0.000175	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—melanoma	6.65e-05	0.000166	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—melanoma	6.65e-05	0.000166	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—melanoma	6.65e-05	0.000166	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—melanoma	6.59e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—melanoma	6.59e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—melanoma	6.59e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—melanoma	6.3e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—melanoma	6.25e-05	0.000156	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—melanoma	6.08e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—melanoma	6.08e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAPK1—melanoma	5.95e-05	0.000148	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—melanoma	5.81e-05	0.000145	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—melanoma	5.81e-05	0.000145	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—melanoma	5.75e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—melanoma	5.75e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—melanoma	5.75e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—melanoma	5.45e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—melanoma	5.36e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—melanoma	5.36e-05	0.000134	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCB4—melanoma	5.33e-05	0.000133	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC6A11—melanoma	5.02e-05	0.000125	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIP4K2A—melanoma	5.02e-05	0.000125	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTAP—melanoma	4.88e-05	0.000122	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—melanoma	4.78e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PHGDH—melanoma	4.35e-05	0.000108	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LUM—melanoma	4.35e-05	0.000108	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPSE—melanoma	4.26e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CUBN—melanoma	4.19e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—melanoma	4.05e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—melanoma	4.05e-05	0.000101	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—melanoma	4.05e-05	0.000101	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BSG—melanoma	4.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDHD—melanoma	4.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CSPG4—melanoma	4.04e-05	0.000101	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPAM—melanoma	3.92e-05	9.76e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—melanoma	3.84e-05	9.58e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G6—melanoma	3.33e-05	8.3e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—melanoma	3.31e-05	8.25e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—melanoma	3.31e-05	8.25e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—melanoma	3.31e-05	8.25e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—melanoma	3.14e-05	7.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—VCAN—melanoma	2.99e-05	7.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP17A1—melanoma	2.52e-05	6.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNA11—melanoma	2.38e-05	5.94e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FASN—melanoma	2.33e-05	5.81e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—melanoma	2.29e-05	5.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNAQ—melanoma	2.22e-05	5.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD44—melanoma	2.22e-05	5.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—melanoma	2.12e-05	5.29e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—melanoma	1.75e-05	4.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PRKCA—melanoma	1.61e-05	4.01e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ERCC2—melanoma	1.6e-05	3.98e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—melanoma	1.26e-05	3.14e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARG—melanoma	1.22e-05	3.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—melanoma	1.11e-05	2.76e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—melanoma	1.09e-05	2.73e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—melanoma	9.66e-06	2.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—melanoma	9.57e-06	2.39e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—melanoma	8.35e-06	2.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—melanoma	5.89e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—melanoma	4.81e-06	1.2e-05	CbGpPWpGaD
